Skip to main navigation
Iovance Biotherapeutics
  • News
  • Investors
  • Email Alerts
  • Patients
  • Join Us
  • Contact Us
  • Site Map
  • Contact Us
  • Twitter
  • LinkedIn
 
 
  • Home
  • Our Company
    • About Iovance Biotherapeutics
    • Management
    • Board of Directors
    • Research Partners & Collaborators
  • Our Products
  • Our Science
    • About TIL
    • Our T-cell Therapy Platforms
    • Scientific Publications & Presentations
    • Next Generation Research
  • Our Technology
    • Iovance Cell
      Therapy Center
    • Manufacturing
    • Intellectual Property
  • Our Pipeline
    • Clinical Pipeline
    • Clinical Trials
    • Expanded Access Policy
  • Careers
    • Current Opportunities
    • Our Culture
  • News
  • Investors
  • Email Alerts
  • Patients
  • Join Us
  • Contact Us
  • Site Map
  • Contact Us
  • Twitter
  • LinkedIn

Iovance in the News

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
    • Iovance In The News
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Ownership Summary
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
    • Earnings Estimates
  • Fundamentals
    • Snapshot
    • Trading Statistics
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Ratios
  • Corporate Governance
    • Governance Highlights
    • Committee Composition
Investor Toolkit
  • Print Page
  • RSS
  • Email Alerts
March 11, 2026
Source
Targeted Oncology
Considering Lifileucel Use in Patients With Brain-Metastatic Melanoma
February 6, 2026
Source
Cure
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
November 3, 2025
Source
OncLive
Lifileucel Displays Antitumor Activity in Advanced Nonsquamous NSCLC
May 28, 2025
Source
Milwaukee Journal Sentinel
Wisconsin man first to benefit from newly approved cancer drug
January 3, 2025
Source
Good Morning America
New cancer treatment uses patients' own cells
September 23, 2024
Source
Chicago Sun-Times
Northwest suburban woman is first in the Midwest to receive 'groundbreaking' sk…
February 16, 2024
Source
NBC News
FDA approves groundbreaking treatment for advanced melanoma
Iovance Biotherapeutics
  • News
  • Investors
  • Email Alerts
  • Patients
  • Join Us
  • Contact Us
  • Site Map
  • Contact Us
  • Twitter
  • LinkedIn
© 2026 IOVANCE Biotherapeutics, Inc. All Rights Reserved. IOVANCE logo is a trademark owned
by IOVANCE Biotherapeutics, Inc.
  • Privacy Notice
  • Terms of Use